MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 188 filers reported holding MEDIVATION INC in Q2 2013. The put-call ratio across all filers is 0.41 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $124,486,000 | +87.4% | 2,064,463 | +42.9% | 0.05% | +70.4% |
| Q1 2016 | $66,422,000 | -28.2% | 1,444,581 | -24.5% | 0.03% | -27.0% |
| Q4 2015 | $92,546,000 | +5.5% | 1,914,505 | -7.2% | 0.04% | 0.0% |
| Q3 2015 | $87,699,000 | -45.0% | 2,063,503 | +47.9% | 0.04% | -41.3% |
| Q2 2015 | $159,313,000 | -39.0% | 1,395,035 | -31.0% | 0.06% | -37.6% |
| Q1 2015 | $261,130,000 | +77.9% | 2,023,174 | +37.3% | 0.10% | +77.2% |
| Q4 2014 | $146,760,000 | -11.2% | 1,473,329 | -11.8% | 0.06% | -13.6% |
| Q3 2014 | $165,188,000 | +22.7% | 1,670,768 | -4.3% | 0.07% | +24.5% |
| Q2 2014 | $134,592,000 | +40.3% | 1,746,147 | +17.2% | 0.05% | +35.9% |
| Q1 2014 | $95,928,000 | -5.0% | 1,490,249 | -5.8% | 0.04% | -2.5% |
| Q4 2013 | $100,934,000 | +21.2% | 1,581,544 | +13.9% | 0.04% | +11.1% |
| Q3 2013 | $83,254,000 | +26.4% | 1,388,955 | +3.7% | 0.04% | +16.1% |
| Q2 2013 | $65,884,000 | – | 1,339,088 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |